Thomas Pike's Net Worth
$51.7 Million
Who is Thomas Pike?
Thomas Pike has an estimated net worth of $51.7 Million. This is based on reported shares across multiple companies, which include Accenture plc, MARTIN MARIETTA MATERIALS INC, Quintiles Transnational Holdings Inc., Fortrea Holdings Inc., LABORATORY CORP OF AMERICA HOLDINGS, and ACCENTURE SCA.
SEC CIK
Thomas Pike's CIK is 0001471570
Past Insider Trading and Trends
2023 was Thomas Pike's most active year for acquiring shares with 10 total transactions. Thomas Pike's most active month to acquire stocks was the month of April. 2024 was Thomas Pike's most active year for disposing of shares, totalling 4 transactions. Thomas Pike's most active month to dispose stocks was the month of December. 2023 saw Thomas Pike paying a total of $770,680.69 for 1,321,992 shares, this is the most they've acquired in one year. In 2024 Thomas Pike cashed out on 230,906 shares for a total of $1,578,672.33, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Accenture plc (ACN) Snapshot price: $338
Chief Risk Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.50% | 28 |
—
|
—
| 5.61K |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MARTIN MARIETTA MATERIALS INC (MLM) Snapshot price: $502.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.51% | 59 |
$534.16 | $31,515.44 | 3.96K |
Aug 30
| |||
Form 4
| +1.43% | 55 |
$572.80 | $31,504.00 | 3.9K |
May 31
| |||
Form 4
| +8.25% | 293 |
$581.69 | $170,435.17 | 3.84K |
May 16
| |||
Form 4
| +1.49% | 52 |
$577.71 | $30,040.92 | 3.55K |
Feb 29
| |||
Form 4
| +1.89% | 65 |
$464.59 | $30,198.35 | 3.5K |
Nov 30
| |||
Form 4
| +2.02% | 68 |
$446.41 | $30,355.88 | 3.43K |
Aug 31
| |||
Form 4
| +2.31% | 76 |
$398.04 | $30,251.04 | 3.37K |
May 31
| |||
Form 4
| +12.36% | 362 |
$400.57 | $145,006.34 | 3.29K |
May 11
| |||
Form 4
| +2.95% | 84 |
$359.87 | $30,229.08 | 2.93K |
Feb 28
| |||
Form 4
| +2.97% | 82 |
$366.48 | $30,051.36 | 2.84K |
Nov 30
| |||
Form 4
| +3.25% | 87 |
$347.41 | $30,224.67 | 2.76K |
Aug 31
| |||
Form 4
| +3.44% | 89 |
$339.38 | $30,204.82 | 2.67K |
May 31
| |||
Form 4
| +20.67% | 443 |
—
|
—
| 2.59K |
May 12
| |||
Form 4
| +3.88% | 80 |
$379.40 | $30,352.00 | 2.14K |
Feb 28
| |||
Form 4
| +3.77% | 75 |
$403.51 | $30,263.25 | 2.06K |
Nov 30
| |||
Form 4
| +4.14% | 79 |
$381.25 | $30,118.75 | 1.99K |
Aug 31
| |||
Form 4
| +4.55% | 83 |
$363.65 | $30,182.95 | 1.91K |
May 28
| |||
Form 4
| +26.98% | 388 |
—
|
—
| 1.83K |
May 13
| |||
Form 4
| +6.68% | 90 |
$336.87 | $30,318.30 | 1.44K |
Feb 26
| |||
Form 4
| +133.22% | 770 |
—
|
—
| 1.35K |
May 14
| |||
Form 4
|
∞
| 578 |
—
|
—
| 578 |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Quintiles Transnational Holdings Inc. (IQV) Snapshot price: $243.07
Vice Chair, Pres R&D Solutions
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +380.72% | 146.88K |
—
|
—
| 185.46K |
Sep 30 - Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fortrea Holdings Inc. (FTRE) Snapshot price: $20.09
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +126.39% | 73.09K |
$22.39 | -$1,177,758.78 | 130.92K |
Aug 19
| |||
Form 4
| +20.91% | 10K |
$24.81 | $248,066.00 | 57.83K |
May 29
| |||
Form 4
| +139.14% | 27.83K |
$32.35 | -$400,913.55 | 47.83K |
Jan 9
| |||
Form 4
|
∞
| 20K |
$25.23 | $504,640.00 | 20K |
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LABORATORY CORP OF AMERICA HOLDINGS (LH) Snapshot price: $223.91
Pres & CEO Clinical Business
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||